CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
-
Souped-up VPNs play 'cat and mouse' game with Iran censors
-
Attacked Russian tanker drifting toward Libya: Italian authorities
-
Coroner 'not satisfied' boxer Hatton intended to take own life
-
Stocks drop, as oil rises as Mideast war persists
-
Vanishing glacier on Germany's highest peak prompts ski lift demolition
-
Chuck Norris, roundhouse-kicking action star, dead at 86: family
-
Supreme leader says Iran dealt enemies 'dizzying blow'
-
Audi team principal Wheatley in shock exit after two races
-
Spurs boss Tudor hopes for 'nice surprises' in relegation fight
-
Arsenal must prove they are winners in League Cup final, says Arteta
-
Record-breaking heat wave grips western US
-
Liverpool showdown brings back 'beautiful memories' for PSG coach Luis Enrique
-
IRA bomb victims drop civil court claim against Gerry Adams
-
Ntamack returns for Toulouse to face France rival Jalibert
-
Trump calls NATO allies 'cowards' over Iran
-
French jihadist jailed for life for Islamic State crimes against Yazidis
-
Chuck Norris, action man who inspired endless memes, dead at 86: family
-
Action movie star Chuck Norris has died: family statement
-
England stars have 'last chance' to earn World Cup spots: Tuchel
-
League Cup final a 'big moment' for Man City, says Guardiola
-
Injured Ronaldo misses Portugal World Cup friendlies
-
Liverpool condemn 'cowardly' racist abuse of Konate
-
Far from war, global fuel frustrations mount
-
German auto exports to China plunged a third in 2025: study
-
Coach Valverde to leave Bilbao at end of season
-
'Decimated'? The Iranian leaders killed in Israeli-US war
-
Mistral chief calls for European AI levy to pay creatives
-
Liverpool suffer Salah blow in chase for Champions League
-
Mahuchikh soars to world indoor high jump gold, Hodgkinson cruises
-
Spain include Joan Garcia as one of four new call-ups
-
Salah ruled out of Liverpool's Brighton clash
-
Ship crews ration food in Iran blockade: seafarers
-
Kuwait refinery hit as Iran marks New Year under shadow of war
-
England recall Mainoo, Maguire for pre-World Cup matches
-
Jerusalem's Muslims despair as war shuts Al-Aqsa Mosque for Eid
-
'War has aged us': Lebanon's kids aren't alright
-
Snooker great O'Sullivan makes history with highest-ever break
-
Kuwait refinery hit as Iran says missile production 'no concern'
-
India to tackle global obesity with cheap fat-loss jabs
-
Somaliland centre saves cheetahs from trafficking to Gulf palaces
-
China swim sensation Yu, 13, beats multiple Olympic medallist
-
North Korean leader, daughter try out new tank
-
Israel strikes 'decimated' Iran as war roils markets
-
James ties NBA record for most regular-season games in latest milestone
-
Trump's Mideast muddle could play into Xi's hands at planned summit
-
Wembanyama lifts playoff-bound Spurs, Doncic and James fuel Lakers
-
Japan ski paradise faces strains of global acclaim
-
Vinicius, Real Madrid must prove consistency in Atletico derby
-
Kane credits Kompany's Bayern 'evolution' as treble beckons
-
PSG look back to their best, but not yet out of sight in Ligue 1
NYSE - LSE
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can significantly improve the delivery and bioavailability of active therapeutic compounds. "This review article is an important step forward in bringing wider scientific attention to this innovative and transformative technology," said Dr. Cole.
This publication is available on the Company's website www.cttpharmaceuticals.com in the 'Scientific Publications' section. This section includes peer-reviewed articles authored by CTT scientists that contribute to the broader scientific literature in areas relevant to the company's scientific focus. These publications are provided solely for transparency and informational purposes. Additional publications will be added as they become available.
CTT Pharma
813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
M.A.Colin--AMWN
